Laura Dillon

Laura Dillon

Company: Incendia Therapeutics

Job title: Vice President, Translational Medicine & Bioinformatics


The Evolving Regulatory Landscape for AI-Powered Drug and Diagnostic Development: An Expert Panel 3:00 pm

What can we expect to change based on this guidance, and what does this mean for pharma clinical development?        What impact should we expect to see in the near-term vs. long-term? What additional evidence needs to be collected to drive that next wave of change?   How can clinical development teams get ahead of these anticipated…Read more

day: Day 1 Track B PM

Implementing Digital Pathology to Characterize Immune Exclusion for Patient Stratification 12:30 pm

Utilizing digital pathology to identify and characterize immune exclusion for patient stratification  Generating data on tumor heterogeneity to inform interpretation of digital-pathology derived assessment of immune phenotypes  Translating digital pathology from a research tool to a robust and informative diagnostic tool for biomarker discovery Read more

day: Day 1 Track A AM

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.